GLENMEDE TRUST CO NA - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 231 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$15,000
+7.1%
904
+4.1%
0.00%
Q2 2020$14,000
+16.7%
868
-18.8%
0.00%
Q1 2020$12,0000.0%1,0690.0%0.00%
Q4 2019$12,000
+20.0%
1,069
+48.7%
0.00%
Q3 2019$10,000
+66.7%
719
+26.8%
0.00%
Q2 2019$6,0000.0%5670.0%0.00%
Q1 2019$6,000
-14.3%
5670.0%0.00%
Q4 2018$7,000
-98.3%
567
-97.4%
0.00%
-100.0%
Q3 2017$414,00021,4620.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,370,017$181,2959.31%
Novo Holdings A/S 3,377,768$73,162,4554.83%
Parallel Advisors, LLC 3,724,573$80,674,2512.72%
TANAKA CAPITAL MANAGEMENT INC 35,539$7702.24%
Shay Capital LLC 350,000$7,581,0001.49%
Shay Capital LLC 350,000$7,581,0001.49%
S&T BANK/PA 350,924$7,6011.37%
Birchview Capital, LP 50,000$1,0830.85%
Clearview Wealth Advisors LLC 34,275$742,3970.75%
Granite Investment Partners, LLC 795,076$17,221,3460.72%
View complete list of CORCEPT THERAPEUTICS INC shareholders